China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) Short Interest Update

Posted by Scott Moore on Mar 27th, 2024

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD – Get Free Report) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 43,400 shares, a growth of 909.3% from the February 29th total of 4,300 shares. Currently, 2.7% of the shares of the company are sold short. Based on an average trading volume of 75,400 shares, the days-to-cover ratio is presently 0.6 days.

China Jo-Jo Drugstores Trading Down 4.1 %

CJJD stock traded down $0.14 during midday trading on Wednesday, reaching $3.28. 4,257 shares of the company’s stock traded hands, compared to its average volume of 97,809. China Jo-Jo Drugstores has a 52 week low of $1.56 and a 52 week high of $47.90. The company has a 50-day moving average price of $3.58 and a two-hundred day moving average price of $4.08.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of China Jo-Jo Drugstores in a report on Wednesday. They set a “sell” rating on the stock.

View Our Latest Research Report on China Jo-Jo Drugstores

Institutional Investors Weigh In On China Jo-Jo Drugstores

A hedge fund recently bought a new stake in China Jo-Jo Drugstores stock. Jane Street Group LLC acquired a new position in China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 31,451 shares of the company’s stock, valued at approximately $112,000. Jane Street Group LLC owned approximately 0.59% of China Jo-Jo Drugstores as of its most recent filing with the Securities & Exchange Commission. 45.26% of the stock is currently owned by hedge funds and other institutional investors.

About China Jo-Jo Drugstores

(Get Free Report)

China Jo-Jo Drugstores, Inc, together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming.